These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 16104747)

  • 1. Comparison of the ATP binding sites of protein kinases using conformationally diverse bisindolylmaleimides.
    Bartlett S; Beddard GS; Jackson RM; Kayser V; Kilner C; Leach A; Nelson A; Oledzki PR; Parker P; Reid GD; Warriner SL
    J Am Chem Soc; 2005 Aug; 127(33):11699-708. PubMed ID: 16104747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Configurational stability of bisindolylmaleimide cyclophanes: from conformers to the first configurationally stable, atropisomeric bisindolylmaleimides.
    Barrett S; Bartlett S; Bolt A; Ironmonger A; Joce C; Nelson A; Woodhall T
    Chemistry; 2005 Oct; 11(21):6277-85. PubMed ID: 16075446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isoenzyme specificity of bisindolylmaleimides, selective inhibitors of protein kinase C.
    Wilkinson SE; Parker PJ; Nixon JS
    Biochem J; 1993 Sep; 294 ( Pt 2)(Pt 2):335-7. PubMed ID: 8373348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acyclic N-(azacycloalkyl)bisindolylmaleimides: isozyme selective inhibitors of PKCbeta.
    Faul MM; Gillig JR; Jirousek MR; Ballas LM; Schotten T; Kahl A; Mohr M
    Bioorg Med Chem Lett; 2003 Jun; 13(11):1857-9. PubMed ID: 12749884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitors of protein kinase C. 1. 2,3-Bisarylmaleimides.
    Davis PD; Hill CH; Lawton G; Nixon JS; Wilkinson SE; Hurst SA; Keech E; Turner SE
    J Med Chem; 1992 Jan; 35(1):177-84. PubMed ID: 1732526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of alternative approaches for the synthesis of macrocyclic bisindolylmaleimides.
    Bartlett S; Nelson A
    Org Biomol Chem; 2004 Oct; 2(19):2874-83. PubMed ID: 15455163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationship of N-methyl-bisindolylmaleimide derivatives as cell death inhibitors.
    Katoh M; Dodo K; Fujita M; Sodeoka M
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3109-13. PubMed ID: 15896957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of bisindolylmaleimides related to GF109203x and their efficient conversion to the bioactive indolocarbazoles.
    Roy S; Eastman A; Gribble GW
    Org Biomol Chem; 2006 Sep; 4(17):3228-34. PubMed ID: 17036110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aryl-indolyl maleimides as inhibitors of CaMKIIdelta. Part 3: Importance of the indole orientation.
    Lu Q; Chen Z; Perumattam J; Wang DX; Liang W; Xu YJ; Do S; Bonaga L; Higaki J; Dong H; Liclican A; Sideris S; Laney M; Dugar S; Mavunkel B; Levy DE
    Bioorg Med Chem Lett; 2008 Apr; 18(7):2399-403. PubMed ID: 18337095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and biological evaluation of 3,4-diarylmaleimides as angiogenesis inhibitors.
    Peifer C; Stoiber T; Unger E; Totzke F; Schächtele C; Marmé D; Brenk R; Klebe G; Schollmeyer D; Dannhardt G
    J Med Chem; 2006 Feb; 49(4):1271-81. PubMed ID: 16480264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aryl-indolyl maleimides as inhibitors of CaMKIIdelta. Part 2: SAR of the amine tether.
    Levy DE; Wang DX; Lu Q; Chen Z; Perumattam J; Xu YJ; Higaki J; Dong H; Liclican A; Laney M; Mavunkel B; Dugar S
    Bioorg Med Chem Lett; 2008 Apr; 18(7):2395-8. PubMed ID: 18334295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards configurationally stable bisindolylmaleimide cyclophanes: potential tools for investigating protein kinase function.
    Bartlett S; Nelson A
    Chem Commun (Camb); 2004 May; (9):1112-3. PubMed ID: 15116210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclization strategies for the synthesis of macrocyclic bisindolylmaleimides.
    Faul MM; Krumrich CA
    J Org Chem; 2001 Mar; 66(6):2024-33. PubMed ID: 11300896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aryl-indolyl maleimides as inhibitors of CaMKIIdelta. Part 1: SAR of the aryl region.
    Levy DE; Wang DX; Lu Q; Chen Z; Perumattam J; Xu YJ; Liclican A; Higaki J; Dong H; Laney M; Mavunkel B; Dugar S
    Bioorg Med Chem Lett; 2008 Apr; 18(7):2390-4. PubMed ID: 18334294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of AX4697, a bisindolylmaleimide exo-affinity probe that labels protein kinase C alpha and beta.
    Liu Y; Wu J; Weissig H; Betancort JM; Gai WZ; Leventhal PS; Patricelli MP; Samii B; Szardenings AK; Shreder KR; Kozarich JW
    Bioorg Med Chem Lett; 2008 Nov; 18(22):5955-8. PubMed ID: 18774710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of novel bisindolylmaleimides that inhibit vascular endothelial cell proliferation.
    Braña MF; Añorbe L; Tarrasón G; Mitjans F; Piulats J
    Bioorg Med Chem Lett; 2001 Oct; 11(20):2701-3. PubMed ID: 11591505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A practical method for the synthesis of indolylaryl- and bisindolylmaleimides.
    Roy S; Roy S; Gribble GW
    Org Lett; 2006 Oct; 8(21):4975-7. PubMed ID: 17020350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactive multivariate analysis of bisindolylmaleimides as potent protein kinase C antagonists.
    Mager PP
    Drug Des Discov; 1993; 10(3):231-48. PubMed ID: 8268394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors of protein kinase C. 3. Potent and highly selective bisindolylmaleimides by conformational restriction.
    Bit RA; Davis PD; Elliott LH; Harris W; Hill CH; Keech E; Kumar H; Lawton G; Maw A; Nixon JS
    J Med Chem; 1993 Jan; 36(1):21-9. PubMed ID: 8421286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions of LY333531 and other bisindolyl maleimide inhibitors with PDK1.
    Komander D; Kular GS; Schüttelkopf AW; Deak M; Prakash KR; Bain J; Elliott M; Garrido-Franco M; Kozikowski AP; Alessi DR; van Aalten DM
    Structure; 2004 Feb; 12(2):215-26. PubMed ID: 14962382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.